SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Vong John

(Last)

(First)

(Middle)

1668 S. GARFIELD AVE

2ND FLOOR

(Street)

ALHAMBRA

91801

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Apollo Medical Holdings, Inc. [ AMEH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	12/15/2023		A		1,813⁽¹⁾	A	$0	6,714	D
Common Stock	12/15/2023		A		1,813⁽²⁾	A	$0	8,527	D
Common Stock	12/15/2023		A		1,813⁽³⁾	A	$0	10,340	D
Common Stock	12/15/2023		A		1,813⁽⁴⁾	A	$0	12,153	D
Common Stock	12/15/2023		A		7,100⁽⁵⁾	A	$0	19,253⁽⁶⁾⁽⁷⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, 226 shares of restricted stock will vest on December 31, 2023, and the remaining 1,587 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024.

2. Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, 226 shares of restricted stock will vest on December 31, 2023, and the remaining 1,587 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024.

3. Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, 226 shares of restricted stock will vest on December 31, 2023, and the remaining 1,587 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024.

4. Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, 226 shares of restricted stock will vest on December 31, 2023, and the remaining 1,587 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024.

5. Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, 887 shares of restricted stock will vest on December 31, 2023, and the remaining 6,213 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024.

6. Includes 18,511 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 2,829 shares, of which 942 shares will vest on each of July 11, 2024 and July 11, 2025 and 945 shares will vest on July 11, 2026; (ii) 570 shares, which will vest in three equal annual installments beginning on November 30, 2024; (iii) 760 shares, which will vest upon achievement of certain pre-established performance goals; (iv) 1,813 shares, of which 226 shares will vest on December 31, 2023 and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024, subject to the achievement of certain pre-established performance goals; (v) 1,813 shares, of which 226 shares will vest on December 31, 2023 and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024, subject to the achievement of certain pre-established performance goals;

7. (cont.) (vi) 1,813 shares, of which 226 shares will vest on December 31, 2023 and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024, subject to the achievement of certain pre-established performance goals; (vii) 1,813 shares, of which 226 shares will vest on December 31, 2023 and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024, subject to the achievement of certain pre-established performance goals; and (viii) 7,100 shares, of which 887 shares will vest on December 31, 2023, and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024.

	/s/ John Vong	12/19/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.